SCHEMBL6738514

SCHEMBL6738514

O=C(O)CCCBr.O=C1CCC(=O)N1O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.39
SLC22A6 Q4U2R8 1/20 0.39
TSHR P16473 3/20 0.37
NFKB1 P19838 1/20 0.37
PMP22 Q01453 1/20 0.37
BBOX1 O75936 1/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
GAA P10253 1/20 0.36
PTGS1 P23219 4/20 0.35
PTGS2 P35354 4/20 0.35
CAMK2A Q9UQM7 1/20 0.34
CYP1A2 P05177 2/20 0.34
MAPK1 P28482 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
F13A1 P00488 3/20 0.33
PTGER3 P43115 1/20 0.33
PTGER2 P43116 1/20 0.33
GABRR3 A8MPY1 1/20 0.33
GABRP O00591 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1060246 0.94 TSHR (0.43) LMNASLC22A6TSHRNFKB1PMP22
SCHEMBL9576050 0.94 TSHR (0.43) LMNASLC22A6TSHRNFKB1PMP22
Glutarate SCHEMBL9485824 0.90 SLC22A6 (0.50) LMNASLC22A6TSHRNFKB1PMP22
Adipic Acid SCHEMBL29427201 0.90 LMNA (0.50) LMNASLC22A6TSHRNFKB1PMP22
Adipic Acid SCHEMBL906129 0.90 LMNA (0.50) LMNASLC22A6TSHRNFKB1PMP22
Glutarate SCHEMBL28487046 0.90 SLC22A6 (0.50) LMNASLC22A6TSHRNFKB1PMP22
Azelaic Acid SCHEMBL28918234 0.88 TSHR (0.52) LMNASLC22A6TSHRNFKB1PMP22
Octanedioate SCHEMBL1394807 0.88 TSHR (0.52) LMNASLC22A6TSHRNFKB1PMP22
Octanedioate SCHEMBL6037661 0.88 TSHR (0.52) LMNASLC22A6TSHRNFKB1PMP22
Sebacic Acid SCHEMBL28228671 0.88 TSHR (0.52) LMNASLC22A6TSHRNFKB1PMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE38416-E1 NUCLEOTIDE BASES COMPRISING PYRAZOLO(3,4-D)PYRIMIDINES USED FOR MEDICAL DIAGNOSIS, THERAPY, HYBRIDIZATION, ANTISENSE AGENTS OR REPORTER MOLECULES EPOCH BIOSCIENCES, INC. 2004-02-03 US disclosed
US-5849482-A Crosslinking oligonucleotides EPOCH PHARMACEUTICALS, INC. (US) 1998-12-15 US disclosed
US-5824796-A MEDICAL DIAGNOSIS WITH TARGET DNA OR RNA FOR ENZYME INHIBITORS EPOCH PHARMACEUTICALS, INC. (US) 1998-10-20 US disclosed
EP-0842186-A1 CROSS-LINKING OLIGONUCLEOTIDES MICROPROBE CORPORATION (US) 1998-05-20 EP disclosed
WO-1996040711-A1 CROSS-LINKING OLIGONUCLEOTIDES MICROPROBE CORPORATION (US) 1996-12-19 WO disclosed
EP-0661979-A4 CROSS-LINKING OLIGONUCLEOTIDES FOR ENZYME-MEDIATED TRIPLE STRAND FORMATION. MICROPROBE CORP (US) 1995-09-13 EP disclosed
EP-0661979-A1 CROSS-LINKING OLIGONUCLEOTIDES FOR ENZYME-MEDIATED TRIPLE STRAND FORMATION MICROPROBE CORPORATION (US) 1995-07-12 EP disclosed
WO-1993003736-A1 CROSS-LINKING OLIGONUCLEOTIDES FOR ENZYME-MEDIATED TRIPLE STRAND FORMATION MICROPROBE CORPORATION (US) 1993-03-04 WO disclosed
EP-0472648-A4 CROSSLINKING OLIGONUCLEOTIDES 1992-09-16 EP disclosed
EP-0472648-A1 CROSSLINKING OLIGONUCLEOTIDES MICROPROBE CORPORATION (US) 1992-03-04 EP disclosed
WO-1990014353-A1 CROSSLINKING OLIGONUCLEOTIDES MICROPROBE CORPORATION (US) 1990-11-29 WO disclosed